The genuine normal seed contains 41 source assertions, five product objects and 33 reference identities. All are preserved. Sixteen genuinely cached references bring the total to 49; two direct human ligand-binding annotations bring the decision count to 43. The source GOA, UniProt, selected publication and Reactome records are unchanged. Default Falcon timed out after 90 seconds; the configured Perplexity Lite fallback returned HTTP 401 insufficient_quota. Both terminal receipts are preserved. These are manual notes, not a provider report.
The integrated core is the alpha3 contribution to canonical alpha1/alpha2/alpha3 collagen VI units and extracellular beaded microfibrils: GO:0030020, GO:0005589 and GO:0001527. The official structural-term comment permits extracellular matrix collagens. Source-specific proteomic identification is not described as an isolated tensile measurement. Human alpha3 N- and C-terminal interfaces contribute directly to assembly; this is performed structural work, not merely a requirement inferred from a knockout. PMID:11027693(https://pubmed.ncbi.nlm.nih.gov/11027693/), PMID:16613849(https://pubmed.ncbi.nlm.nih.gov/16613849/), PMID:23869615(https://pubmed.ncbi.nlm.nih.gov/23869615/).
All five official products reconstruct exactly as 3,177, 2,971, 1,036, 2,570 and 1,237 residues. All retain the N5 region; only products 1, 2 and 4 retain the collagenous and C-terminal regions. N5 retention therefore does not establish canonical incorporation for products 3 or 5. The historical N9–C5 assembly control is not silently equated to the current N10-containing displayed sequence, and retained architecture is not equivalent to measured activity. Original N10-specific antibody experiments detect protein in MG-63 extracellular matrix, without testing every modern product. The independent product consultation supplies exact VSP, sequence and domain maps, with its original indexed-text access explicitly attributed. PMID:1339440(https://pubmed.ncbi.nlm.nih.gov/1339440/), PMID:1689238(https://pubmed.ncbi.nlm.nih.gov/1689238/).
Actual human SaOS-2 N-terminal deletion experiments retain secretion of monomers, dimers and tetramers in constructs that retain the helix and C-terminal domains. N5-containing constructs support substantially more end-to-end microfibril formation. The C-terminal series shows that C1 can support initial incorporation while C5 supports higher-order matrix assembly. These engineered constructs do not establish activity of the natural short products that lack the entire helix and C-terminal region. Original indexed Methods, Results and figure captions were read; no new PDF-pixel inspection is claimed. Original N-terminal study, original C-terminal study.
No new microfibril-assembly process is added. Actual GO:0160054 definition, parents, children and complete current annotation records were inspected. Its current annotation usage is concentrated on THSD4 orthologs, and the same-role check does not resolve its intended scope for collagen VI structural chains. This is a biological-scope/convention question, not an absolute exclusion of structural subunits or an argument from donor count. The direct alpha3 interfaces remain positive participation evidence and are described in the existing structural core.
The original human recombinant N9–N2 paper was read in all six original page images, 4283–4288. The construct is described as historical F019 positions 1–1586 with a terminal tag, expressed in 293 cells; those positions are not substituted for modern canonical coordinates. Affinity columns and mapped fragments directly support GO:0008201 heparin binding and GO:0005540 hyaluronic acid binding by IDA. These are two distinct, non-core MF additions, with no new process or extra formal core. The official typed ancestors and descendants exclude overlap with the 41 existing source terms and with each other; neither query returned a more-specific child. PMID:1425570(https://pubmed.ncbi.nlm.nih.gov/1425570/), original PMC page images.
Heparin binding is salt-sensitive: most retained material elutes at modest salt concentration. Figure 7/Table I distinguishes positive N9/N6/N3 fragments from negative N4/N5/N7 fragments. Hyaluronan retention resists high salt, with most elution requiring urea; this is not a measured physiological affinity constant or receptor mechanism. The tested large heparan-sulfate proteoglycan was inactive, so the heparin result is not generalized to heparan-sulfate binding. Accessibility in assembled collagen or every intact splice product remains unknown. The original PDF challenge is preserved separately from successful image recovery, and the genuine abstract cache remains unchanged.
The automatic GO:0004867 inhibitor mapping is removed. Current InterPro entries support the Kunitz fold, but native human recombinant C5 lacks trypsin binding at the tested 7 micromolar concentration and lacks inhibition in the reported peptide and nidogen-cleavage assays. Engineered binding-loop mutants gain activity; known inhibitors provide positive controls. These experiments contradict the functional transfer to the tested native sequence without negating the fold, every protease interaction or every splice product. Original mutagenesis Methods, Tables 2–3 and Figure 4 text were read; the independent inhibitor peer and ROOT separately inspected the actual figure/table images. PMID:8681942(https://pubmed.ncbi.nlm.nih.gov/8681942/), PMID:8805527(https://pubmed.ncbi.nlm.nih.gov/8805527/). The structural studies are consistent with a Kunitz-like architecture rather than proof of inhibitor activity. PMID:7533217(https://pubmed.ncbi.nlm.nih.gov/7533217/), PMID:9265624(https://pubmed.ncbi.nlm.nih.gov/9265624/).
The positive endotrophin experiments are retained at their actual scope. The 2012 supplement identifies mouse C5 NP_034056 residues 2590–2657. Purified fragment in the lower chamber increases MS-1 migration; macrophage experiments use a different coculture arrangement. Human staining antigen is not a human functional assay. No human fragment NEW or second formal core is inferred automatically, and no named-receptor prerequisite is imposed. PMID:23041627(https://pubmed.ncbi.nlm.nih.gov/23041627/).
Human keratocyte processing work distinguishes free C5 from more abundant larger C5-containing fragments and identifies BMP1-dependent cleavage. The protease performs the cleavage; COL6A3 is not assigned that catalytic activity. Later defined-domain and cell-surface assays challenge generalized direct ANTXR binding, with appropriate toxin-positive controls and distinct NG2 binding to assembled collagen. Those negative binding results do not erase the earlier positive mouse migration experiment. PMID:31346034(https://pubmed.ncbi.nlm.nih.gov/31346034/), PMID:36185380(https://pubmed.ncbi.nlm.nih.gov/36185380/).
Original human aortic Tables I–III identify CO6A3_HUMAN with 16, 164 and 57 unique peptides across NaCl, guanidine and SDS extracts. Human-vein Figure 3 explicitly names CO6A3 and uses fivefold scaling for its displayed spectral count. These are target-specific extracellular observations, without isolated mechanics or all-product resolution. PMID:20551380(https://pubmed.ncbi.nlm.nih.gov/20551380/), PMID:27068509(https://pubmed.ncbi.nlm.nih.gov/27068509/).
Original feeder-matrix Table 1 detects COL6A3 in human placental stromal hPSF and immortalized hPSF matrices at normalized counts 1.25 and 8.41. The four mouse feeder columns and HUES1 are ND. The colon/liver workbook contains the same alpha3 group in row 95 of two sheets, not two independent experiments; principal, alternative and legacy accessions are grouped. PMID:23658023(https://pubmed.ncbi.nlm.nih.gov/23658023/), PMID:25037231(https://pubmed.ncbi.nlm.nih.gov/25037231/).
Original atrial HTML/Table 1 detects alpha3(VI) in GuHCl input, glycoprotein enrichment and glycopeptide detection. The cell-derived ECM table groups COL6A1/2/3 as collagen VI rather than quantifying alpha3 separately. Both external original HTML sources are distinguished from their shorter unchanged caches. Tissue-proteomics supplementary workbook requests returned HTML challenges; the exact alpha3 table entry remains unverified even though independent ECM biology is established. PMID:27559042(https://pubmed.ncbi.nlm.nih.gov/27559042/), PMID:28327460(https://pubmed.ncbi.nlm.nih.gov/28327460/), PMID:28675934(https://pubmed.ncbi.nlm.nih.gov/28675934/).
The alternative-chain paper also contains direct human alpha3 staining. Its Methods, Results and Figure 7 caption specify monoclonal 3C4 detection in skeletal/cardiac muscle, lung and liver extracellular matrix, with monoclonal negative controls. That positive target experiment is distinct from engineered alpha4 association with endogenous alpha1/alpha2. The title foregrounding other chains is not a reason to reject alpha3 localization. PMID:18400749(https://pubmed.ncbi.nlm.nih.gov/18400749/), original indexed text.
The original urinary study and public NHLBI companion database identify a historical COL6A3 isoform5/NP_476508 entry with one peptide. The actual peptide sequence and equivalence to modern product 5 were not recovered. Retain fraction detection as non-core, without resolving intravesicular topology or product identity. PMID:19056867(https://pubmed.ncbi.nlm.nih.gov/19056867/), original database.
Human EPS-urine isolation/MS and contamination context were read, but the attempted supplements remain HTML rather than readable workbooks. That source's exact COL6A3 record remains unverified, so its annotation is UNDECIDED. Other positive vesicle studies do not replace the missing source-specific entry. PMID:23533145(https://pubmed.ncbi.nlm.nih.gov/23533145/).
The public PXD000608 MaxQuant proteinGroups row 315 identifies a COL6A3 group with 70 group-unique peptides, 55 and 56 in the two EV pools and 14 and 4 in corresponding supernatants. The row has no reverse or contaminant flag; parameters specify 1% peptide and protein FDR. Deposited output and design files were read directly, without claiming full-article Methods or independent spectral reanalysis. Group detection does not identify every isoform or a vesicle-biogenesis function. PMID:24769233(https://pubmed.ncbi.nlm.nih.gov/24769233/), PXD000608.
The Bethlem clinical abstract supports disease context and prior alpha3 linkage, but the unavailable full text does not settle the muscle-development process assertion. That TAS row remains UNDECIDED; the independently established canonical complex remains accepted. PMID:8782832(https://pubmed.ncbi.nlm.nih.gov/8782832/).
The exact rat Col6a3 donor carries response to glucose by IEP from the high-glucose connective-tissue study. Increased transcripts and fibrils support contextual gene-expression response rather than glucose sensing or metabolism. Porcine same-term RCA/HDA records support the ortholog premise at their actual proteomic scope. Current mouse alias records and target experimental records support extracellular location without reconstructing the historical PAINT node. Self-inclusion and donor counts are not failure evidence. PMID:8494053(https://pubmed.ncbi.nlm.nih.gov/8494053/), PMID:22261194(https://pubmed.ncbi.nlm.nih.gov/22261194/).
The current ARBA00093710 target match is the exact FunFam 000003/000004/000021 plus Metazoa branch; the separate SF90 branch does not match target SF13. All 17 retrieved donor records and five source-term joins are published literally in the index. Original source qualifiers remain unchanged.
All 13 current Reactome summaries were read and 972 target paths reconstructed. Intracellular precursor assembly, extracellular destination and substrate degradation are distinct stages. Broad ligand sets do not establish an isolated alpha3 interaction with every named protein. In particular, the NCAM summary names other collagen classes although its graph reaches COL6A3; no direct NCAM experiment is manufactured. ER-lumen locations are retained as non-core biosynthetic context. The GO-CAM index yields no target match.
The index contains precise official definitions, typed ligand coverage, original table records, deposited output fields, product maps and source/read hashes. Bounded peer reads are attributed separately from personal source reads. Literal anchors remain short and are not repeated here. Ordinary validation and the independent whole-candidate peer are separate final checks.
Ordinary validation, status and rendering passed on the final candidate. One advisory remains because the two exosome source assertions have different actions: the verified historical urinary target is non-core, while the EPS-urine target remains undecided. The difference follows the actual source evidence and is not resolved by mechanical action uniformity. Normal1 validation passed and its dry-run status reported INITIALIZED versus expected DRAFT; the ordinary updater supplied DRAFT before normal4 passed.
The exact five-leaf delta from the first fixed draft contains three schema-vocabulary corrections in the inhibitor propagation metadata (one root cause and two source-status fields), the derived status, and an access-flag correction for the partial 28675934 cache. Its full paper remains unavailable; the protected cache's own metadata is untouched. No annotation action, original source field, product identity, reference identity or core changed. Original product objects are preserved with added, scoped descriptions. The five short formal anchors total 3/3/4/12 words by paper; including the glucose phrase in reason/index mirrors gives aggregate totals 3/3/12/12. No anchor is duplicated in these notes.
The normal validator added the correct GO:0005589 entry to the isolated term cache. Both cache versions and the single-line insertion are retained, without resetting the runtime cache. The remaining 280 authenticated tooling files are unchanged.
Fresh applicability passed at d202cf89c7f36565b4a40b998989e04a9885f995 using 349 complete PR inventories, full project/catalog/queue authentication and the actual-current-main oversized-PR merge-base with 21,581 paths. The finite packet has 30 ADD paths and 27 protected paths. All 15 main tooling roots remain unchanged. Twenty shared source-path occurrences with COL6A1 and COL6A2 were compared by exact blob identity.
One PANTHER family metadata file differs only at _fetch_info.fetched_date between the genuine new retrieval and the published COL6A1 revision. Family scientific metadata and the entire membership CSV are identical. The publication composition uses the published metadata variant from PR 4941 head 37f1aa9535e07fb7aface73af24c1ca4e44e0044; both exact variants and the one-leaf diff are preserved. This is published, locally peer-accepted content, not a claim of exact-head GitHub approval. Initial source selection and the research workspace remain unchanged. ROOT alone qualifies immediate publisher preimages, creates genuine history and publishes after whole review.
The current GO:0001527 microfibril definition describes extracellular matrix components and discusses fibrillins and microfibril-associated proteins. Its two definition references concern fibrillin microfibrils: the complete abstract of PMID:27026396(https://pubmed.ncbi.nlm.nih.gov/27026396/) and the abstract, introduction and structural sections of the original PMID:31226403 review were checked. Full text of the former was unavailable. Those references explain the fibrillin emphasis; they do not demonstrate that the ontology excludes collagen VI. The current exact-term annotation query returns five human collagen VI records, including a TAS record for each of COL6A1, COL6A2 and COL6A3. This is evidence of curator usage, distinct from the direct alpha3 assembly experiments. The microfibril location is retained for the demonstrated beaded collagen VI matrix, without equating its molecular architecture with fibrillin microfibrils or assigning assembly competence to every splice product.
The N5-containing construct anchor from PMID:11027693 now includes the complete matrix-deposition clause. The heparin-binding interpretation also explicitly preserves the inactive large basement-membrane heparan-sulfate proteoglycan tested in PMID:1425570 (original page 4287). This negative result limits extrapolation to physiological heparan-sulfate partners; it does not negate the positive heparin experiment. The Reactome secretion reference describes the ER-luminal and extracellular annotations together as distinct stages, and repeated inspection wording has been removed from the other affected reference assessments.